Zydus Lifesciences Reports Strong Financial Growth Amid Market Challenges
Zydus Lifesciences has recently experienced a change in evaluation, reflecting strong performance metrics. The company reported a profit after tax of Rs 2,358.67 crore, with a consistent annual growth rate in net sales and operating profit. Its low debt-to-equity ratio and solid return on equity highlight financial stability.
Zydus Lifesciences, a prominent player in the Pharmaceuticals & Biotechnology sector, has recently undergone an adjustment in evaluation, reflecting notable underlying trends in its performance metrics. The company has demonstrated a robust financial profile, highlighted by a consistent annual growth rate in net sales of 10.41% and an impressive operating profit growth of 24.54%. In the latest quarter, Zydus Lifesciences reported a profit after tax (PAT) of Rs 2,358.67 crore, marking a growth of 20.80% over the last six months. The company maintains a low debt-to-equity ratio of 0.06 times, indicating strong financial health and stability. Additionally, the return on equity (ROE) stands at an average of 19.49%, showcasing effective utilization of shareholders' funds.
Despite facing challenges in the past year, where the stock generated a return of -7.73%, Zydus Lifesciences has consistently delivered positive results for eight consecutive quarters. The stock is currently trading at a fair value compared to its peers, with a price-to-book value of 4.2, suggesting an attractive valuation.
For those interested in further insights, Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
